Founded in 2015, Amiko is growing to become a global provider of digital medicines
About Amiko Digital Health Limited
Amiko was born out of insight and inspiration. We believe in the transformative role technology will play in improving healthcare practice. By putting together advanced sensor technologies, seamless connectivity and cutting-edge Artificial Intelligence we deliver our vision of care – to enable and support care professionals with high-definition data and tools, to allow patients to benefit from more personalized care decisions, to generate efficiency and insights in standard practice. Amiko is developing a full range of technologies to collect data on delivery systems usage, including inhalers, nasal sprays, nebulizers, injectables, or pharmaceutical primary packaging. Our sensor technology platforms are:
Proprietary and Patent Protected
Designed for add-on or integrated devices
Ideally suited for low-cost, low-power solutions
Amiko’s flagship product is Respiro®, a digital therapeutic solution that enables advanced tracking of respiratory medication use for improved adherence and treatment effectiveness.
Reply is a leading Consulting, Systems Integration and Digital Services company. Reply is listed on Borsa Italiana SpA since December 2000. In 2016, Reply recorded over $1 Billion in revenue.
Sanner develops, manufactures, and markets plastic packaging and components for pharmaceutical, medical, and household products, with the knowhow of over 55 years on the market. Sanner is a fourth generation family business, with a global manufacturing presence.
Salisbury House, 31 Finsbury Circus, London, UK
Via Washington, 105,